Skip to main content
RPG Life Sciences Limited logo

RPG Life Sciences Limited — Investor Relations & Filings

Ticker · RPGLIFE ISIN · INE105J01010 LEI · 335800O9C9JKWKXY5Y66 BSE.NS Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2025-04-08 Board/Management Inform…
Country IN India
Listing BSE.NS RPGLIFE

About RPG Life Sciences Limited

https://www.rpglifesciences.com

RPG Life Sciences Limited is an integrated pharmaceutical enterprise engaged in the development, manufacturing, and marketing of a diverse range of generic and branded formulations, as well as Active Pharmaceutical Ingredients (APIs). The company operates across several therapeutic segments, including nephrology, oncology, cardiology, rheumatology, and gastroenterology. It maintains a significant presence in the immunosuppressant market, providing critical medications for transplant recipients. With a focus on research and development, the organization produces complex molecules and finished dosages that cater to both domestic and international healthcare markets. Its manufacturing facilities adhere to stringent global quality standards, enabling the supply of essential medicines to regulated and semi-regulated markets worldwide. The portfolio includes a mix of legacy brands and specialty products designed to address chronic and acute medical conditions.

Recent filings

Filing Released Lang Actions
Change in Management
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the appointment of a Senior Management Personnel, Ms. Sheetal Gaba, as Chief Human Resources Officer. It references compliance with SEBI regulations and provides details about the appointment and the individual's profile. There is no financial data, earnings information, or report attached. The content clearly fits the category of announcements related to changes in senior management or board members. Therefore, the document is best classified as Board/Management Information (MANG). The document length is short and focused solely on management appointment, confirming this classification with high confidence.
2025-04-08 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter from the National Stock Exchange of India Limited to RPG Life Sciences Limited regarding non-compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically about delayed payment of fines and the risk of freezing promoter holdings. It references a prior letter and requests the company to update the Board's comments on the NEAPS portal. The content is regulatory in nature, dealing with compliance reminders and procedural updates rather than financial results, management changes, or detailed reports. It does not contain financial statements or detailed report data but is a formal regulatory communication and compliance reminder. Therefore, it fits best under Regulatory Filings (RNS).
2025-03-27 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window for insiders ahead of the declaration of audited financial results for the fiscal year ending March 31, 2025. It references compliance with insider trading regulations and states that the date of the board meeting for declaring audited results will be intimated later. The document does not contain any financial data, results, or detailed report content. It is a regulatory announcement related to trading restrictions prior to financial results disclosure. Given the short length (1416 characters) and nature of the content, this is not the financial report itself but an announcement related to regulatory compliance and trading restrictions. Therefore, it fits best under Regulatory Filings (RNS).
2025-03-25 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (NSE and BSE) regarding an order received from the Income Tax Department. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events. The content details an assessment order received on March 20, 2025, concerning income tax for the financial year 2022-23, including the company's response and potential appeal. The document is short (3159 characters) and serves as a regulatory disclosure of a material event rather than a financial report or earnings release. It does not contain financial statements or detailed financial analysis but is a compliance announcement about a legal/regulatory event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding an upcoming Analyst/Institutional Investors meet scheduled for March 5, 2025. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of a meeting event, not a financial report, presentation, or detailed analysis. The document length is short (1666 characters) and it does not contain financial data or detailed presentation materials, only a notification of the event. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about an investor meeting.
2025-02-25 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short notification letter addressed to stock exchanges regarding the completion of a transaction involving the transfer of surplus vacant leasehold land. It references a prior intimation and confirms the execution of a deed to consummate the transaction. There are no financial statements, detailed financial data, or regulatory certifications present. The document is an update on a specific transaction rather than a full report or detailed announcement. Given its brevity (1150 characters) and content, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.